Publication | Open Access
Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial
14
Citations
23
References
2021
Year
Sanofi Pasteur.
| Year | Citations | |
|---|---|---|
Page 1
Page 1